Jane Street
FENC icon

Jane Street’s Fennec Pharmaceuticals FENC Stock Holding History

Jane Street’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,044
Closed -$185K – 11983
2025
Q4 		$185K Sell
24,044
-48,587
-67% -$399K ﹤0.01% 9792
2025
Q3 		$680K Buy
72,631
+22,642
+45% +$196K ﹤0.01% 7170
2025
Q2 		$415K Buy
49,989
+35,271
+240% +$241K ﹤0.01% 7278
2025
Q1 		$89.6K Buy
+14,718
New +$94.5K ﹤0.01% 8860
2024
Q4 		– Sell
-19,339
Closed -$96.7K – 9737
2024
Q3 		$96.7K Sell
19,339
-465
-2% -$2.69K ﹤0.01% 9000
2024
Q2 		$121K Buy
19,804
+4,250
+27% +$35.3K ﹤0.01% 8661
2024
Q1 		$173K Buy
+15,554
New +$156K ﹤0.01% 8267
2023
Q2 		– Sell
-88,240
Closed -$734K – 8922
2023
Q1 		$734K Buy
88,240
+62,374
+241% +$579K ﹤0.01% 5617
2022
Q4 		$248K Buy
25,866
+11,359
+78% +$101K ﹤0.01% 7332
2022
Q3 		$118K Buy
+14,507
New +$99.6K ﹤0.01% 8558
2021
Q3 		– Sell
-24,278
Closed -$177K – 10154
2021
Q2 		$177K Buy
+24,278
New +$162K ﹤0.01% 8919
2020
Q3 		– Sell
-19,896
Closed -$166K – 7360
2020
Q2 		$166K Buy
+19,896
New +$148K ﹤0.01% 6485

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Jane Street's FENC Position: Q1 2026 in Review

Jane Street sold out of Fennec Pharmaceuticals (FENC) in Q1 2026, closing a stake of 24,044 shares — an estimated $185K sold.

Jane Street first reported a position in FENC in Q2 2020 and held it in 12 quarters. The position peaked at $734K in Q1 2023. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • Jane Street reported no remaining Fennec Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 24,044 Fennec Pharmaceuticals shares in Q1 2026, an estimated $185K.
  • Jane Street first reported a position in Fennec Pharmaceuticals in Q2 2020 and held it in 12 quarters.
  • Jane Street's Fennec Pharmaceuticals position peaked at $734K in Q1 2023.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.